Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2020
Sep. 30, 2019
Current Assets    
Cash and cash equivalents $ 263.1 $ 399.0
Trade receivables, net 297.2 217.4
Receivables from long-term manufacturing contracts 166.2 181.1
Inventories, net 424.3 176.6
Prepaid expenses and other current assets 93.7 49.1
Total current assets 1,244.5 1,023.2
Property, plant, and equipment, net 331.6 140.3
Operating lease right-of-use assets 161.4 0.0
Intangible assets, net 1,093.6 454.9
Goodwill 1,143.1 578.0
Other long-term assets 55.7 32.2
Total Assets 4,029.9 2,228.6
Current Liabilities    
Trade accounts payable 264.9 236.2
Liabilities from long-term manufacturing contracts and advances 168.4 158.2
Current portion of long-term debt 36.3 0.0
Accrued compensation 87.8 73.2
Other current liabilities 211.6 121.7
Total current liabilities 769.0 589.3
Long-term debt 1,674.8 619.5
Accrued pension and postretirement healthcare 159.3 131.3
Operating lease liabilities 126.2 0.0
Deferred Income Tax Liabilities, Net 187.6 73.6
Other long-term liabilities 57.9 45.1
Total Liabilities 2,974.8 1,458.8
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 63.9 shares issued, 74.7 and 62.7 shares outstanding) 0.0 0.0
Additional paid-in capital 719.7 345.3
Retained earnings 504.4 599.5
Treasury stock (1.1 and 1.2 shares) (44.9) (50.1)
Accumulated other comprehensive loss (142.6) (140.6)
Hillenbrand Shareholders’ Equity 1,036.6 754.1
Noncontrolling interests 18.5 15.7
Total Shareholders’ Equity 1,055.1 769.8
Total Liabilities and Shareholders’ Equity $ 4,029.9 $ 2,228.6